Dns Capital — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

Glympse Bioglympsebio.comJul 2020Acquired

Cambridge, MA biotechnology company developing injectable synthetic biomarkers for noninvasive disease staging and treatment monitoring.

BiotechCambridge, US

Gabriel Kwong(Executive Officer)in Sangeeta Bhatia in Roopom Banerjee(Executive Officer)in

Board Theresia Gouw(Director)in Amy Schulman(Director)Stan Lapidus(Director)in

Co-investorsGreatPoint Ventures Acrew Capital ARCH Venture Partners Aspect Ventures Catalio Capital Management CRV (Charles River Ventures)+6 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.